StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSSFree Report) in a report released on Sunday morning. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Read Our Latest Stock Report on MLSS

Milestone Scientific Price Performance

MLSS opened at $0.95 on Friday. The stock’s 50 day moving average price is $0.83 and its 200 day moving average price is $0.87. The stock has a market cap of $74.00 million, a P/E ratio of -13.57 and a beta of 1.10. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.10.

Insider Activity at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

Institutional investors and hedge funds have recently bought and sold shares of the business. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific in the 3rd quarter worth approximately $91,000. Geode Capital Management LLC boosted its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in Milestone Scientific during the third quarter worth approximately $48,000. 5.79% of the stock is owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Featured Articles

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.